Clinical Trial Update: Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on CD70 CAR NK cells for primary refractory or early-relapsed diffuse large B-cell lymphoma and Hodgkin lymphoma; the study is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Hodgkin Lymphoma

Drugs mentioned

• CD70.CAR NK Cells (CD70-targeted CAR natural killer cells)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Large B-cell Lymphoma, Hodgkin Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING